0. Chronic obstructive pulmonary disease. Implementing NICE guidance. 3 rd . Edition - April 2012. NICE clinical guideline 101. What this presentation covers. Background Scope Definition Recommendations Costs and savings
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Chronic obstructive pulmonary disease
Implementing NICE guidance
3rd. Edition - April 2012
NICE clinical guideline 101
BODE = body mass index, airflow obstruction, dyspnoea and exercise tolerance
FEV1 = forced expiratory volume in 1 second
FVC = forced vital capacity
Consider a diagnosis of COPD for people who are:
* Symptoms should be present to diagnose COPD in people with mild airflow obstruction
** Or FEV1 < 50% with respiratory failure
Patient with COPD
Manage those that are present as below
Patients with COPD should have access to the wide range of skills available from a multidisciplinary team
ICS = inhaled corticosteroid
LABA = long-acting beta2 agonist
LAMA = long-acting muscarinic agonist
Make available to all appropriate people, including those recently hospitalised for an acute exacerbation
Hold at times that suit patients, and in buildings with good access
An individually tailored multidisciplinary programme of care to optimise patients’ physical and social performance and autonomy
Offer to all patients who consider themselves functionally disabled by COPD
Tailor multi-component, multidisciplinary interventions to individual patient’s needs
Costs correct at Feb. 2011.
Costs not updated for 3rd. edition
Visit the NHS Lung Improvement Programme webpages (www.improvement.nhs.uk/lung) for further practical support consistent with implementing the recommendations in this guideline
to go to
Visit NHS Evidence for the best available evidence on all aspects of respiratory diseases, including COPD
Click here to go to the NHS Evidence website
Visit the NPC for further resources supporting the NICE guideline on COPD
Click here to go to the National Prescribing Centre website
Process:Proportion of people with COPD who have a current individualised comprehensive management plan, which includes high-quality information and educational material about the condition and its management, relevant to the stage of disease.
a)Proportion of people with COPD who are offered inhaled and oral therapies in accordance with NICE guidance.
b) Proportion of people with COPD who receive their inhaled and oral therapies as part of an individualised comprehensive management plan.
Process: Proportion of people with COPD who had a comprehensive clinical and psychosocial assessment in the previous 12 months which includes degree of breathlessness, frequency of exacerbations, validated measures of health status and prognosis, presence of hypoxaemia and comorbidities.
Proportion of people with COPD who smoke who are offered the full range of evidence-based smoking cessation support.
Proportion of people with COPD meeting appropriate criteria who receive an effective, timely and accessible multidisciplinary pulmonary rehabilitation programme.
Process:Proportion of people who have had an exacerbation of COPD who are given individualised written advice on early recognition of future exacerbations, management strategies (including appropriate provision of antibiotics and corticosteroids for self-treatment at home) and a named contact.
Proportion of people with COPD with oxygen saturation less than or equal to 92% when stable, who are assessed for LTOT in accordance with NICE guidance by a specialist oxygen service.
Process: Proportion of people with COPD receiving LTOT, who have had a review in the previous 12 months by a specialist oxygen service in accordance with NICE guidance, as part of the integrated clinical management of their COPD.
a) Proportion of people with COPD admitted to hospital with an exacerbation who are cared for by a respiratory team
b) Proportion of people with COPD admitted to hospital with an exacerbation, and who meet the criteria for early supported discharge, who are placed on a specialist early supported discharge scheme with appropriate community support.
Proportion of people discharged from hospital following an admission with an exacerbation of COPD, who are reviewed within 2 weeks of discharge.
Proportion of people with advanced COPD, and their carers, who receive palliative care that addresses physical, social and emotional needs.
To open the links in this slide set right click over the link and choose ‘open link’